Shuhei Kurosawa, MD, PhD^1*, Yoshimitsu Shimomura^2*, Ken Ishiyama, MD, PhD³, Kyoko Fuse⁴, Yutaka Shimazu^5*, Noriko Doki, MD, PhD⁶, Naoyuki Uchida^7*, Masatsugu Tanaka^8*, Satoshi Takahashi⁹, Masatoshi Sakurai¹⁰, Hikaru Kobayashi^11*, Yuta Katayama, MD, PhD¹², Satoru Takada^13*, Kazutaka Ozeki^14*, Hirohisa Nakamae^15*, Fumihiko Ishimaru^16*, Yoshinobu Kanda^17*, Tatsuo Ichinohe^18*, Yoshiko Atsuta, MD, PhD^19* and Hidehiro Itonaga, MD, PhD²⁰

¹Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan
²Department of Hematology, Kobe City Hospital Organization, Kobe, Japan
³Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan
⁴Department of Haematopoietic Cell Therapy, Niigata University Medical and Dental Hospital, Niigata, Japan
⁵Department of Hematology, Kyoto University Hospital, Kyoto, Japan
⁶Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
⁷Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan
⁸Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
⁹Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
¹⁰Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
¹¹Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan
¹²Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
¹³Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan
¹⁴Department of Hematology and Oncology, Konan Kosei Hospital, Konan, Japan
¹⁵Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan
¹⁶Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan
¹⁷Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
¹⁸Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
¹⁹Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan
²⁰Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki city, NSK, Japan

Pier Rovatti, MD^1,2,3*, Marco Punta^1,4*, Giorgio Orofino^1,3,5*, Matteo Maria Naldini^6*, Matteo Giovanni Carrabba^7*, Massimo Bernardi, MD^7*, Jacopo Peccatori, MD^7*, Bernhard Gentner, MD^7,8*, Fabio Ciceri^3,7*, Luca Vago, MD, PhD^1,3,9 and Cristina Toffalori^1,3*

¹Unit of Immunogenetics, Leukemia Genomics and Immunobiology, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
²Unit of Hematology and Bone Marrow Transplantation, IRCCS Ospedale San Raffaele
³Vita-Salute San Raffaele University, Milan, Italy
⁴Unit of Immunogenomics, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
⁵Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
⁶Translational Stem Cell and Leukemia Unit, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy, ITA
⁷Unit of Hematology and Bone Marrow Transplantation, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
⁸San Raffaele Telethon Institute For Gene Therapy (SR-Tiget), IRCCS San Raffaele, Milan, Italy
⁹Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. Ospedale San Raffaele, Milano, NA, Italy

Tingting Yang^1*, Bingqian Jiang^1*, Yi Luo¹, Yanmin Zhao^1*, Guifang Ouyang^2*, Jian Yu^1*, Jianping Lan^3*, Ying Lu^4*, Xiaoyu Lai^1*, Baodong Ye, MD^5*, Yi Chen^6*, Lizhen Liu^1*, Yang Xu^7*, Qunyi Guo^8*, Pengfei Shi^9*, Haowen Xiao^10*, Huixian Hu^11*, Huarui Fu^1*, Yishan Ye, MD^1*, Xinyu Wang^1*, Jie Sun^1*, Weiyan Zheng, MD^1*, Jingsong He^1*, Yi Zhao^1*, Wenjun Wu^1*, Zhen Cai^1*, Guoqing Wei^1*, He Huang^1* and Jimin Shi^1*

¹Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Department of Hematology, Ningbo First Hospital, Ningbo, China
³Department of Hematology, Zhejiang Provincial People’s Hospital, Hangzhou, China
⁴Department of Hematology, Yinzhou People's Hospital, Ningbo, China
⁵The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
⁶Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
⁷The Second Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China
⁸Department of Hematology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical College, Taizhou, China
⁹Department of Hematology, The Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹⁰Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine,, Hangzhou, China
¹¹Department of Hematology, Jinhua Central Hospital, Jinhua, China

Livius Penter, MD^1,2,3,4, Nicoletta Cieri, MD, PhD^1,3,4, Katie Maurer, MD, PhD^1,3,4, Haoxiang Lyu, BS^5*, Wesley S Lu, BS^5*, Giacomo Oliveira, PhD^1,3,4*, Satyen H Gohil^6*, Caleb Lareau, PhD^7*, Leif S Ludwig, MD, PhD^8,9*, Shuqiang Li, PhD^3,4,5*, Jerome Ritz, MD^1,3, Jacqueline S. Garcia, MD^1,10, Robert J. Soiffer, MD^1,3, Kenneth J. Livak, PhD^3,5* and Catherine J Wu, MD^1,3,4

¹Harvard Medical School, Boston, MA
²Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Broad Institute of MIT and Harvard, Cambridge, MA
⁵Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
⁶Haematology, University College Hospital, London, United Kingdom
⁷Departments of Genetics and Pathology, Stanford University, Stanford, CA
⁸Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
⁹Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Nikki Blosser, BScPharm^1*, Sunita Ghosh, PhD, P.Stat^2*, Bhavi Desai, BSc^3*, Nicole Crisp, MN, NP^4*, Baljit Randhawa, MN, NP^5*, Grace Beda, MSc, RD^5*, Andrew Daly, MD, FRCPC⁶, Jan Storek, MD, PhD⁷ and Kareem Jamani, MD, MPH⁸

¹Tom Baker Cancer Centre, Calgary, AB, Canada
²Cross Cancer Institute, Edmonton, AB, Canada
³University of Calgary, Calgary, AB, Canada
⁴Cross Cancer Institute, Edmonton, Canada
⁵Tom Baker Cancer Centre, Calgary, Canada
⁶Tom Baker Cancer Center, Calgary, AB, CAN
⁷The University of Calgary Department of Medicine, Calgary, Canada
⁸University of Calgary, Cumming School of Medicine, Calgary, AB, Canada

Jonathan Allen Webster, MD¹, Richard J. Jones, MD², Amanda Blackford^2*, Audra Shedeck^2*, Richard F. Ambinder, MD³, Lode J. Swinnen⁴, Nina Wagner-Johnston, MD⁵, Ephraim Joseph Fuchs, MD, MBA², Javier Bolanos-Meade, MD, KHS^6*, Philip Imus, MD⁷, Challice L. Bonifant, MD, PhD⁸, Heather Jill Symons, MD^5*, Tania Jain, MD², Gabrielle T. Prince, MD^2*, Mark J. Levis, MD, PhD⁹, Leo Luznik, MD¹⁰ and Ivana Gojo, MD⁷

¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
²Johns Hopkins University, Baltimore, MD
³Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD
⁴Johns Hopkins Cancer Center, Baltimore, MD
⁵Johns Hopkins Hospital, Baltimore, MD
⁶Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
⁷Johns Hopkins, Baltimore, MD
⁸Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
⁹Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD
¹⁰Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD

Alicja Sadowska-Klasa, MD^1,2, Sezen Ozkok^1*, Hu Xie^1*, Wendy Leisenring^1,3*, Danniel Zamora^1,3*, Sachiko Seo, MD, PhD⁴, Jordan Sheldon^1*, Stephanie J. Lee^1,3, Margaret L Green^1,3* and Michael Boeckh, MD^1,3*

¹Fred Hutchinson Cancer Center, Seattle, WA
²Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
³University of Washington, Seattle, WA
⁴Department of Hematology and Oncology, Dokkyo Medical University,, Tochigi, JPN

Alessandro Cattoni, MD^1,2*, Maria Laura Nicolosi^1*, Giulia Capitoli^3*, Alberto Gadda^3*, Silvia Molinari^1*, Louka Sotiri^3*, Andrea Buonsante^3*, Simona Orlandi^3*, Francesca Vendemini^4*, Giorgio Ottaviano, MD^1*, Alberto Gaiero^5*, Graziella Fichera^5*, Andrea Biondi, MD^4,6,7,8 and Adriana Balduzzi, MD^4,8

¹Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
²Milano-Bicocca University, Milano, Italy
³Milano-Bicocca University, Monza, Italy
⁴Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
⁵UOC Pediatria e Neonatologia Gaslini Savona, Savona, Italy
⁶Tettamanti Research Center, Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
⁷Centro Ricerca Tettamanti, Clinica Pediatrica, Università Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza, Italy
⁸School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy

Liam Anthony Wynn, BSc^1*, Mónica M Rivera-Franco, MD^2*, Roger Horton, PhD^1*, Daniel Gibson, BSc^1*, Hanadi Rafii, MD^2*, Fernanda Volt, MSc^3*, Chantal Kenzey, RA^3*, Barbara Cappelli, MD^4,5*, Graziana Scigliuolo, PharmD^4,5*, Vanderson Rocha, MD, PhD, MS^3,6*, Annalisa Ruggeri, MD, PhD^3,7*, Ryad Tamouza, MD, PhD^8* and Éliane Gluckman, MD, PhD³

¹Anthony Nolan Cell Therapy Centre, Nottingham, UK., Nottingham, United Kingdom
²Eurocord, Hôpital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris Cité, Paris, France, Paris, France
³Eurocord, Hôpital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris Cité, Paris, France
⁴Monacord, Centre Scientifique De Monaco, Monaco, Monaco
⁵Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris Cité, Paris, France
⁶Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas, Faculty of Medicine, São Paulo University, São Paulo, Brazil., São Paulo, Brazil
⁷Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
⁸Univ Paris Est Créteil, INSERM U955, IMRB, F-94010 Créteil, France., Créteil, France

Eugenia Accorsi Buttini^1*, Cristina Doran^2*, Michele Malagola^1*, Mohamad Mohty, MD, PhD², Vera Radici, MD^1*, Mirko Farina, MD^1*, Marco Galli^1*, Enrico Morello, MD^1*, Nicola Polverelli, MD³, Sofia Terlizzi^1*, Simona Bernardi, PhD^4,5*, Domenico Russo, MD, PhD^1* and Eolia Brissot^2*

¹Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
²Sorbonne Université Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Centre de Recherche Saint-Antoine (CRSA), Paris, France
³Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
⁴Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST Spedali Civili, Brescia, Italy, Brescia, Italy
⁵Research Center Ail (CREA), Chair of Hematology Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy

Daehun Kwag^1*, Jong-Wook Lee, MD², Gi-June Min^3*, Sung-Soo Park^4*, Silvia Park^5*, Jae-Ho Yoon, MD³, Sung-Eun Lee, MD^6*, Byung-Sik Cho^3*, Ki-Seong Eom^3*, Yoo-Jin Kim³, Seok Lee³, Hee-Je Kim³, Chang-Ki Min^3* and Seok-Goo Cho^3*

¹Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, Th, Seoul, South Korea
²Department of Hematology, Seoul St. Mary's Hospital Catholic University of Korea, Seoul, South Korea
³Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁴Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
⁵Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
⁶Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Houston, TX

Miriam Mozaffari Jovein, MD^1*, Gabriele Ihorst, Ph.D^2*, Jesus Duque Afonso, MD¹, Ralph Wäsch, MD³, Claudia Wehr, MD^3*, Hartmut Bertz, MD^3*, Justus Duyster, MD^3*, Robert Zeiser, MD⁴, Jürgen Finke, MD³ and Florian Scherer, MD³

¹Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
²Clinical Trials Unit, University Medical Center Freiburg, Freiburg, Germany
³Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
⁴Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany

Yomna Eissa^1*, Eshrak Al-Shaibani^2*, Igor Novitzky-Basso, MD^1*, Ivan Pasic, MD^1*, Wilson Lam, MD¹, Jose-Mario Capo-chichi^3*, Arjun D. Law, MD^1*, Fotios Michelis, MD, PhD^1*, Auro Viswabandya, MD¹, Armin Gerbitz, MD, PhD^1*, Rajat Kumar, MD, FRCPC¹, Jonas Mattsson, MD, PhD^4* and Dennis D. H. Kim¹

¹University Health Network / Princess Margaret Cancer Centre, Toronto, ON, Canada
²Princess Margaret Cancer Centre / University Health Network, Toronto, ON, Canada
³Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Ron Ram, MD¹, Ido Wolf, MD^2*, Odelia Amit, MD^3*, Ronit Yerushalmi, MD⁴, Yakir Moshe, MD, PhD^3*, Noga Shem-Tov, MD^5*, Gil Fridberg^3*, Ivetta Danylesko, MD^4*, Irit Avivi Mazza, MD^3* and Avichai Shimoni, MD^6*

¹Bone Marrow Transplant Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Oncology Institution, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
³BMT Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Department of Bone Marrow Transplantation and Cellular Therapy, Chaim Sheba Medical Center, Ramat Gan and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat Gan, Israel
⁶Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan, Israel

Avichai Shimoni, MD^1*, Ronit Yerushalmi, MD^1*, Noga Shem-Tov, MD^2*, Ivetta Danylesko, MD^3*, Abraham Avigdor, MD² and Arnon Nagler, MD⁴

¹Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan, Israel
²Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat Gan, Israel
³Department of Bone Marrow Transplantation and Cellular Therapy, Chaim Sheba Medical Center, Ramat Gan and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel